Positive association of anticytoskeletal endothelial cell antibodies and cardiac allograft rejection

Human Immunology

Volumn 69, Issue 3, 2008, Pages 143-148

  Álvarez Márquez, Antonia ^a   Aguilera, Isabel ^a   Blanco, Rosa María ^b   Pascual, Domingo ^b   Encarnación Carrizosa, Mercedes ^a   Álvarez López, Maria Rocío ^b   Wichmann, Ingeborg ^a   Núñez Roldán, Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

AECA; Allograft rejection; Antibody mediated rejection; Anticytoskeletal cell antibodies; Heart transplantation

Indexed keywords

ACTIN ANTIBODY; ANTIBODY; CYTOKERATIN; CYTOKERATIN ANTIBODY; ENDOTHELIAL CELL ANTIBODY; TUBULIN; TUBULIN ANTIBODY; UNCLASSIFIED DRUG; VIMENTIN; VIMENTIN ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ACTINS; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; KERATINS; MALE; MICE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS; TUBULIN; VIMENTIN;

EID: 41549107035     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.01.015     Document Type: Article

References (19)

1. Holmen C., Christensson M., Pettersson E., Bratt J., Stjärne P., Karrar A., et al. Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int 66 (2004) 1049
2. Bodolay E., Csipo I., Gal I., Sipka S., Gyimesi E., Szekanecz S., et al. Anti-endothelial cell antibodies in mixed connective tissue disease: frequencyand association with clinical symptoms. Clin Exp Rheumatol 22 (2004) 409
3. Nakagawa Y., Saito K., Morioka T., Tomita Y., Takahashi K., and Oite T. The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin Transplant 16 Suppl 8 (2002) 51
4. Le-Bas Bernardet S., Hourmant M., Coupel S., Bignon J.D., Souillou J.P., and Charreau B. Non HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 3 (2003) 167
5. Jurcevic S., Aisnswoth M.E., Pomerance A., Smith J.D., Robinson D.R., Dunn M.J., et al. Anti-vimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 71 (2001) 886
6. Hosenpud J.D., Shipley G.D., and Wagner C.R. Cardiac allograft vasculopathy: current concepts, recent developments and future directions. J Heart Lung Transplant 11 (1992) 9
7. Rose M.L. Role of antibodies in transplant-associated cardiac allograft vasculopathy. Z Kardiol 89 Suppl 9 (2000) IX/11-5
8. Azimzadeh A.M., Pfeiffer S., Wu G.S., Schröder C., Zhou H., Zhorn III G.L., et al. Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates. Am J Transplant 5 (2005) 2349
9. Rose M.L. Non HLA antibodies and the role of the immune response in transplant rejection. Curr Opin Organ Transplant 11 (2006) 439
10. Horvathova M., Jahnova E., and Nyulassy S. Detection of antiendothelial cell antibodies in patients with connective tissue diseases by flow cytometry and their relation to endothelial cell activation. Physiol Res 51 (2002) 613
11. Jamin C., Dugue C., Alard J.E., Jousse S., Saraux A., Guillevin L., et al. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to HSP60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum 52 (2005) 4028
12. Bordron A., Revelen R., D'arbonneau M., Dueymes M., Renaudineau Y., Jamin C., et al. Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 124 (2001) 492
13. Castillo S., Revelen R., Bordron A., Renaudineau Y., Dueymes M., and Youinou P. Anti-endothelial cell reactivity, the unresolved enigma. Int J Immunopathol Pharmacol 142 (2001) 109
14. Fredrich R., Toyoda M., Czer L.S., Galfayan K., Galera O., Trento A., et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 67 (1999) 385
15. Faulk W.P., Rose M., Meroni P., Del Papa N., Torry R.J., Labarrere C.A., et al. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 60 (1999) 826
16. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710
17. Muramatsu M., Miyagi M., Ishikawa Y., Aikawa A., Mizuiri S., Ohara T., et al. Estimation of damaged tubular epithelium in renal allografts by determination of vimentin expression. Int J Urol 11 (2004) 954
18. Ronda N., Meroni P.L., Raschi E., and Borghi M.O. Anti-endothelial cell autoantibodies. In: Shoenfeld Y., Gershwin M.E., and Meroni P.-L. (Eds). Autoantibodies. 2nd ed. (2006), Elsevier 725
19. Praprotnik S., Blank M., Moroni P.L., Rozman B., Eldor A., and Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. The pathogenic and diagnostic implications. Arthritis Rheum 44 (2001) 1484